Frontiers in Nutrition (Sep 2023)

Polysaccharides: potential bioactive macromolecules for Alzheimer’s disease

  • Gong Peng,
  • Ming Li,
  • Zhaoli Meng

DOI
https://doi.org/10.3389/fnut.2023.1249018
Journal volume & issue
Vol. 10

Abstract

Read online

Alzheimer’s disease (AD) is one of the leading causes of death and disability. AD is a devastating disease that has caused an overwhelming burden. However, no disease-modified treatment was discovered. The approval of sodium oligomannate (GV-971) in mild-moderate AD patients has attracted great attention to investigate the role of saccharides in AD. Therefore, summarizing and explaining the role of saccharides in AD is urgent and promising. Recent studies showed that polysaccharides (PSs) potentially benefit AD in vitro and in vivo. PSs could alleviate the pathological damage and improve cognitive symptoms via (1) antagonizing the toxicity of abnormal amyloid-beta and tau proteins; (2) attenuating oxidative stress and proinflammation; (3) rebuilding neuroplasticity. PSs exhibit one-multiple pathological hits of AD. However, a thorough chemical investigation is needed for further study.

Keywords